Time

Event

8:00 am – Lobby Level

Registration Opens

9:45 am – 2nd Floor

Welcome Remarks

• Sara Jane Demy, Founder & CEO, Demy-Colton

10:00 am – 2nd Floor 

“Big Think" Fireside Chat

Biopharma: What the Future Looks Like

• James Flynn, Managing Partner, Deerfield

Interviewed by:

• Sara Jane Demy, Founder & CEO, Demy-Colton

11:00 am – Ground Floor,
Event Hall South

One-to-One Meetings 

11:00 am – 2nd Floor

Spotlight Panel 1A 

Beyond the Cure: The Brave New World of Revolutionary Cancer Therapeutics 

Moderator:

• Erkang Ai, Counsel, Global Regulatory, Hogan Lovells

Panel:

• Gerald Commissiong, CBO, OS Therapies, Inc.
• Gadareth Higgs, Business Development Lead, Circurna
• Richard Kornbluth, President & CSO, Multimeric Biotherapeutics, Inc.
• Julie O’Shaughnessy, COO, Vivodyne
• Daniel Teper, CEO, Naya Therapeutics

11:00 am – 12th Floor 

Spotlight Panel 1B 

Rewiring Minds: Breakthroughs in Brain & CNS Health  

Moderator:

• Ginger Johnson, SVP, Lumanity

Panel:

• Connor Glass, CEO & Founder, Phantom Neuro
• Beth Hoffman, CEO, Origami Therapeutics, Inc.
• Adam Rogers, CEO, NervGen Pharma 
• Arun Swaminathan, CEO, Coya Therapeutics, Inc. 
• Brent Vaughan, CEO & Founder, Eratos Therapeutics

12:00 pm – Ground Floor,
Event Hall South

Lunch

1:00 pm – 2nd Floor 

Dialogue 1A

Rare Disease Therapies: Challenges in Development and Regulatory Pathways

Moderator:

• Chris Vlahos, VP, External Innovation, Acadia Pharmaceuticals

Panel:

• Shelley Hartman, CEO, Aegle Therapeutics Corporation
• Jennifer Schranz, SVP, Global Head, Rare Diseases, Ipsen
• Melindah Sharma, Managing Director, Commercialization, Supply Chain & Venture Capital, Manatt Health
• Rachel Sher, Life Sciences & FDA Partner, Manatt Health

2:00 pm – Ground Floor,
Event Hall South

One-to-One Meetings 

2:00 pm – 2nd Floor

Spotlight Panel 2A

Where Code Meets Cells: Forging the TechBio Future

Moderator:

• Sebastien Latapie, Partner, Avant Bio

Panel:

• Bigyan Bista, SVP & Head of Business Development, Enveda
• Dan Que Pham, Co-Founder & COO, Oncodea
• Irene Rombel, CEO, President & Co-Founder, BioCurie
• Ignacio Willats, Co-Founder & CCO, Mytos

3:10 pm – 2nd Floor 

Spotlight Panel 3A 

Immunity Unleashed: Next-Gen Therapies & Immune Engineering

Moderator:

• Melindah Sharma, Managing Director, Commercialization, Supply Chain & Venture Capital, Manatt Health

Panel:

• Robert Arch, President, Immunophotonics, Inc.
• Frank Bedu-Addo, President & CEO, PDS Biotechnology Corporation
• Michael Montgomery, CMO & Co-Founder, Tidewave Bio
• Wenzhi Tian, CEO, ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
• Ming-Ru Wu, Co-Founder, TroGen Therapeutics

3:10 pm – 12th Floor

Spotlight Panel 3B

Healthspan Horizons: Advancing Longevity Therapeutics 

Moderator:

• Komal Bajaj, Chief Quality Officer, NYC Health + Hospital (Jacobi/NCB)

Panel:

• Thomas Ichim, President & CSO, Immorta Bio
• Marc Jones, CEO, Altoida, Inc.
• Hans Keirstead, Chairman, Immunis, Inc.
• Shreefāl Mehta, Co-Founder & CBO, Repoxegen Therapeutics Inc.

4:15 pm – 2nd Floor

End of Day “Big Think" Plenary Session

The Great Biopharma Reset: Will Today’s Challenging Environment Result in a more Resilient Sector?

Moderator:

• Dennis Purcell, Founder & Senior Advisor, Aisling Capital

Panel:

• Jo Natauri, Founder & Managing Partner, Invidia Capital Management
• Umer Raffat, Equity Research, Evercore ISI
• Philip Ross, Vice Chairman, Global Healthcare Investment Banking, Jefferies LLC
• Eric Schmidt, Biotechnology Analyst, Cantor Fitzgerald

5:30 pm – Location TBA

Networking Reception

Sponsored by EisnerAmper